Prospective Observational Study for the Evaluation of VEOFIX Varisation Staples
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Hallux Valgus
- Sponsor
- Societe dEtude, de Recherche et de Fabrication
- Enrollment
- 81
- Locations
- 1
- Primary Endpoint
- AOFAS Score
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This clinical investigation was led as a post-market clinical follow-up study (post-market device development stage). Therefore, its objectives were as follows:
- To assess functional clinical score's evolution,
- To evaluate patient's satisfaction
- To confirm safety of varisation staples The target population for this study was any adult patient implanted with VEOFIX varisation staples in their intended uses between 15/02/2021 and 15/05/2021.
Patients were implanted and followed as per standard of care led in the investigational site.
The following regulation and guidelines were followed for this investigation:
- Standard ISO 14155:2020 "Good Clinical Practice"undirectly applicable;
- Regulation (UE) 2016/679 (RGPD) ;
- Regulation (UE) 2017/745 (MDR) ;
- MEDDEV 2.12.1;
- Local regulation (loi " jardé ", loi " informatique et libertés "). As per its design, the investigation is considered as involving human beings, and therefore require submission to an ethic committee or declaration to a Competent Authority (ANSM) and CPP. This study was registered on CPP (CPP Ile de France VII).
Investigators
Eligibility Criteria
Inclusion Criteria
- •Man or woman
- •Major patient on the date of surgery
- •Patient with foot pathology requiring Akin osteotomy
- •Patient not opposed to the collection of data
Exclusion Criteria
- •Patient unable to understand and follow the postoperative instructions
- •Patient with a contraindication to the use of the implant
- •Non-implanted patient with a varisation staple
Outcomes
Primary Outcomes
AOFAS Score
Time Frame: 3 and 12 months
To confirm the performance of varisation staples in conservative surgery of Hallux Valgus, according to the indications covered by the CE Marking (Akin's osteotomy) and according to the surgeon's current practice investigator. The scores range from 0 to 100, The average preoperative score was 50 to 60 points. Post-operatively, a score of 80 points is a good post-operative result, with the patient experiencing no or low levels of residual pain and full or partial recovery of joint function. The AOFAS Score is considered excellent between 90 and 100 points, good between 80 and 89, fair between 60 and 79, and poor below 60 points.
Secondary Outcomes
- Patient Satisfaction(3 and 12 months)
- Number of Complications Observed During the Clinical Investigation(12 months)